Evaluation of exenatide versus insulin glargine for the impact on endothelial functions and cardiovascular risk markers

Gurkan E., TARKUN İ., ŞAHİN T., Cetinarslan B., CANTÜRK Z.

DIABETES RESEARCH AND CLINICAL PRACTICE, cilt.106, sa.3, ss.567-575, 2014 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 106 Sayı: 3
  • Basım Tarihi: 2014
  • Doi Numarası: 10.1016/j.diabres.2014.09.046
  • Dergi Adı: DIABETES RESEARCH AND CLINICAL PRACTICE
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.567-575
  • Anahtar Kelimeler: Cardiovascular disease, Type 2 diabetes, Insulin analogues, Exenatide, GLUCAGON-LIKE PEPTIDE-1, TYPE-2 DIABETIC-PATIENTS, C-REACTIVE PROTEIN, METABOLIC SYNDROME, RANDOMIZED-TRIAL, GLP-1 ANALOG, IN-VIVO, RESISTANCE, LIRAGLUTIDE, METFORMIN
  • Kocaeli Üniversitesi Adresli: Evet

Özet

Aims: To demonstrate the efficacy of exenatide versus insulin glargine on endothelial functions and cardiovascular risk markers.